Slide 1: AI-Powered, Portable Brain MRI
AI-POWERED, PORTABLE BRAIN MRI The Swoop® Portable MR Imaging System is Driving the Future of Brain Health Corporate Investor Deck – May 2026 The Hyperfine logo, Swoop, and Portable MR Imaging are registered trademarks of Hyperfine, Inc. The Swoop logo is a trademark of Hyperfine, Inc. PROPERTY OF H
Slide 2: Forward-Looking Statements
Forward-Looking Statements This presentation includes “forward-looking statements” within the meaning of the “safe harbor” provisions of the Private Securities Litigation Reform Act of 1995. Actual results of Hyperfine, Inc. (the “Company”) may differ from its expectations, estimates and projections
Slide 3: MRI is the Clinical Gold Standard, But Capacity and Access Are Limited
MRI is the Clinical Gold Standard, But Capacity and Access Are Limited The MRI You Know The MRI You Wish For High-cost and complex site Significantly less expensive, no requirements limit access shielding or siting required. Available at any healthcare facility Need for highly trained No dedicated p
Slide 4: Large Market Potential Bringing MRI to Multiple Sites of Care
Large Market Potential Bringing MRI to Multiple Sites of Care Sizeable and Growing US TAM1 Through New Sites of Care $1.5B $6B+ $16B+ Inpatient Settings Outpatient Settings Community Settings 2023+ 2025+ 2026+ Adult critical care Emergency departments2 Urgent care facilities 4,000+ Peds critical car
Slide 5: The Swoop System Transforms and Expands the Reach of Brain Imaging
The Swoop System Transforms and Expands the Reach of Brain Imaging Diagnostic Images Captured in Portable, Compact Design Goes Simplified Set Up and Scanning for Multiple Sites of Care Directly to the Patient Broad Usability USING THE SWOOP SYSTEM IMPROVES MRI CAPACITY AND ACCESS WITH MEANINGFUL CLI
Slide 6: Solid Fundamentals: Poised for Commercial Growth
Solid Fundamentals: Poised for Commercial Growth Development, Clinical & Early Compelling STRATEGY Commercial EXPANSION Commercial FOUNDATION • Next Gen Swoop System Launch • First Mover Advantage • Outstanding market feedback on Optive AI image quality Hospital Office International • ~200 Issued Pa
Slide 7: Image Quality Approaching Conventional MRI
Image Quality Approaching Conventional MRI 0.064T New Swoop System 1.5 T Conventional MRI Powered by Optive AI Software Sources: T2 images from Swoop system in 2025 and representative image from 1.5T conventional MRI 7 PROPERTY OF HYPERFINE ©2026. All rights reserved.
Slide 8: Image Quality of Next Gen Swoop System to Drive Broad Adoption
Image Quality of Next Gen Swoop FLAIR (Swoop System) FLAIR (High-field 3T) System to Drive Broad Adoption Image Quality Approaching Conventional MRI Case Study of Swoop System vs. High-Field 3T 63-year-old female with history of prior infarct presenting with new-onset headache. Physicians performed
Slide 9: AI-Enabled Imaging Software
AI-Enabled Imaging Software Advanced, AI-driven image reconstruction to ultra-low field MRI—unlocking clearer images at lower field strengths Reduces noise and blur with deep learning, enhances image clarity and consistency, provides sharper anatomical detail to support confident diagnoses at the po
Slide 10: Robust Commercial Growth Strategy Driven By Diversified Business Verticals
Robust Commercial Growth Strategy Driven By 3 Diversified Business Verticals Hospital Business Office Business International Business • Increase revenue & lower cost • New revenue stream • Increase access to MRI • Improve patient progress • Improve access to imaging • Make MRI available where Value
Slide 11: Hospital Business
Hospital Business • Compelling clinical utility in critical care, emergency triage, neurosurgery and neuro follow up in adults & peds • Strong economic value proposition o Swoop system scans qualify for existing reimbursement (CPT 70551) o Opportunity to increase revenue, cost savings and optimized
Slide 12: Office Business
Office Business • A typical neurologist orders 500–600 MRIs annually1,2 for neurologic conditions such as headaches, dementia, tumor, MS, surgery follow-up • 90% of private neurology practices don’t have on-site MR imaging3 • Affordable and appealing, plug-and-play Swoop system o No specialized siti
Slide 13: International Business
International Business Model 1 Swoop system • Compelling clinical utility transferable globally • Selling primarily into the hospital setting, demonstrated value proposition in remote settings • Optive AI software launched in 10 European languages in Q1’26 • CE Mark and UKCA Mark approval for both t
Slide 14: Scalable Commercialization with US Direct Sales and Global Distribution Network
Scalable Commercialization with US Direct Sales and Global Distribution Network INSTALLED BASE Over 200 Swoop Systems Globally1 DIRECT DISTRIBUTORS Dedicated Selling & Implementation Teams (~15 FTE in Total) 10+ Markets (2 FTE in Total) Healthy US Pricing & Recurring Revenue Swoop System Manufacture
Slide 15: Multiple Catalysts Driving a Durable Revenue Trajectory
Multiple Catalysts Driving a Durable Revenue Trajectory Next-generation Swoop system powered by Optive AI software Future Revenue Catalysts 1 Expanded Sites of Care $5.3 • Growing adoption in ED, hospital clinics, and critical care environments $3.9 • IDN & multi-system placements $3.4 International
Slide 16: Demonstrated Growth and Financial Discipline
Demonstrated Growth and Financial Discipline USD (Millions) Q1’26 Q1’25 YoY Change Revenue $3.9M $2.1M 83% Gross Margin 50.7% 41.3% 940 bps Operating Loss $(8.6)M $(10.9)M 21% Net Cash Burn1 $(8.8)M $(10.1)M 13% Cash, and Cash Equivalents $40.8M $33.1M N/A 16 PROPERTY OF HYPERFINE. ©2026. All rights
Slide 17: Solid Financial Fundamentals
Solid Financial Fundamentals Strong Revenue Growth and Realizing Operating Leverage Key Takeaways REVENUE AND GROSS MARGIN CASH BURN1 • Transitioned to Commercial Stage Organization in 2025 2024 2025 FY26 Guidance 2026 Est. 25 GM%: 50-55% • Next Generation Swoop System 40 $38.4 Launched Mid’25 in U.
Slide 18: Platform Technology Expansion Roadmap
Platform Technology Expansion Roadmap Hyperfine Patents and Know-how are Well Positioned to Deliver in Multiple Markets with Additional Growth AND Value-added Services1 Now Next Future Expanded sequence Mobile for acute care Mobile brain health Neuro offering and private practice Expansion Screening
Slide 19: Leadership Team With Proven Track Record of Success
Leadership Team With Proven Track Record of Success Maria Brett Hale Tom Rob Sainz Chief Administrative Teisseyre, PhD Fasciano, PhD President and Chief Officer and Chief Chief Operating Chief Regulatory Executive Officer Financial Officer Officer and Quality Officer Edmond Rafael Donnay Chi Nguyen
Slide 20: Hyperfine, Inc. Opportunity
Hyperfine, Inc. Opportunity Large TAM Strong Proprietary Broad Indications Prolific Innovation First-Mover Position and Applicability Engine • $16B+ US device market • Portable MR category • Brain imaging of patients of • Image quality approaching across inpatient, outpatient leader all ages convent
Slide 21: AYPERFINE.
AYPERFINE.